| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |